Neutralization enzyme immunoassay for influenza virus.
AUTOR(ES)
Benne, C A
RESUMO
A neutralization enzyme immunoassay (N-EIA) was developed for the detection of antibody titer rises in sera of patients infected with influenza A (H3N2) virus. In this N-EIA, a selected strain of influenza A (H3N2) virus was added to monolayers of LLC-MK2 cells in microtiter plates. After 24 h, the replicated virus could be demonstrated with a virus-specific enzyme-labeled monoclonal antibody. Preincubation of the influenza virus with convalescent-phase sera of patients infected with influenza A (H3N2) virus resulted 1 day later in decreased absorbance values that could be used for calculation of neutralization titers. From use of paired serum samples from 10 patients with a history of flu-like symptoms, the results obtained with N-EIA correlated well (r = 0.83) with those of the standard hemagglutination inhibition test.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=267167Documentos Relacionados
- Evaluation of a rapid enzyme immunoassay for detection of influenza A virus.
- Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus.
- Latex enzyme immunoassay for measuring IgG antibodies to rubella virus.
- Screening and diagnostic performance of enzyme immunoassay for antibody to lymphadenopathy-associated virus.
- Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
